Also trades as: INXB (NASDAQ) · $vol 8M
INBX NASDAQ
Inhibrx Biosciences, Inc.
1W: -4.8%
1M: -3.9%
3M: +40.6%
YTD: +47.4%
1Y: +746.0%
$101.32
-9.25 (-8.37%)
Weekly Expected Move ±23.9%
$57
$83
$109
$135
$160
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$1M
Revenue
+550.0% YoY
$-130M
Net Income
-107.6% YoY
$-132M
Free Cash Flow
+21.8% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-183.9%
ROA-79.6%
ROIC1054.9%
Valuation
P/E-12.1
P/B-75.1
EV/EBITDA-8.8
Leverage
Debt/Equity13.39
Current Ratio3.93
Interest Cov.-9.2x
Quality Scores
Piotroski F1/9
Altman Z0.32
Beneish M0.00